Dr. Paczesny, who was recently awarded an NIH Challenge Grant, leads the graft versus host disease (GVHD) biomarker discovery and validation research. She received her MD and PhD from Paris University, France where she completed her residency and fellowship in Pediatric Hematology/Oncology and Bone Marrow Transplantation. She recently joined the Bone Marrow and Stem Cell Transplant Program at the Indiana University. From 2006 to 2012, she developed proteomics for the diagnosis of acute GVHD, a complication that occurs in approximately half of patients following allogeneic hematopoietic cell transplantation at University of Michigan. At Indiana University, she will pursue leadership in the discovery and validation of biomarkers for complications post-transplant.